<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Late Night Pyq Pyt Marathon (Obg 3)   2025 03 03</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Late Night Pyq Pyt Marathon (Obg 3)   2025 03 03</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                60 Questions | 240 Total Marks | 70 min Duration | ~70.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 60 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 70 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 60</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Late Night Pyq Pyt Marathon (Obg 3)   2025 03 03 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 60</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 60 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 23y woman who is using the combined oral contraceptive pill misses 2 pills in the 3rd week of the pack. What is the next best step? (FMGE JANUARY 2024)", "options": [{"label": "A", "text": "Reassure and continue the packet", "correct": false}, {"label": "B", "text": "Take 2 pills the same day and continue", "correct": true}, {"label": "C", "text": "Continue pills and take extra precaution for 1 week", "correct": false}, {"label": "D", "text": "Start a new packet immediately", "correct": false}], "correct_answer": "B. Take 2 pills the same day and continue", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-122802.png"], "explanation": "<p><strong>Ans. B) Take 2 pills the same day and continue</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ According to the Ministry of Health and Family Welfare, the missed pill guidelines are â€“</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Reassure and continue the packet: Simply continuing the packet without taking the missed pills would increase the risk of pregnancy.</li><li>â€¢ Option A. Reassure and continue the packet:</li><li>â€¢ Option C. Continue pills and take extra precaution for 1 week: This option is more applicable for missing three or more pills, where additional precautions and possibly emergency contraception might be necessary.</li><li>â€¢ Option C. Continue pills and take extra precaution for 1 week:</li><li>â€¢ Option D. Start a new packet immediately: This approach is necessary only when three or more pills are missed in the third week, to avoid a pill-free interval and ensure continued contraceptive protection.</li><li>â€¢ Option D. Start a new packet immediately:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ If one or two combined oral contraceptive pills are missed in the third week, the woman should take the last missed pill as soon as possible, then continue the pack as scheduled, taking two pills in one day if necessary. This minimizes the risk of pregnancy.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 23-year-old woman with eclampsia is on a maintenance dose of MgSOâ‚„. When will you stop MgSOâ‚„? (NEET PG 2024)", "options": [{"label": "A", "text": "Knee jerk presen", "correct": false}, {"label": "B", "text": "RR 18/min", "correct": false}, {"label": "C", "text": "Visual disturbance", "correct": false}, {"label": "D", "text": "Urine output 60ml in 4hr", "correct": true}], "correct_answer": "D. Urine output 60ml in 4hr", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Urine output 60ml in 4hr</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ MgSOâ‚„ should be stopped if the patientâ€™s urine output is less than 30 ml per hour (or 60 ml in 4 hours), as this indicates poor excretion and risk of magnesium toxicity.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not included in the active management of the third stage of labor to prevent post-partum hemorrhage? (INICET MAY 2018)", "options": [{"label": "A", "text": "Uterotonic within 1 minute of delivery", "correct": false}, {"label": "B", "text": "Delayed clamping, cutting and ligation of cord", "correct": false}, {"label": "C", "text": "Gentle massage of uterus", "correct": true}, {"label": "D", "text": "Controlled cord traction", "correct": false}], "correct_answer": "C. Gentle massage of uterus", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Gentle massage of uterus</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The active management of the third stage of labor includes the administration of a uterotonic, controlled cord traction, and assessing uterine tone rather than sustained uterine massage for all women who have received a uterotonic.</li><li>âž¤ Ref: https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1</li><li>âž¤ Ref:</li><li>âž¤ https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An 18-year-old girl with primary amenorrhea presents to the OPD. She has Tanner stage IV secondary sexual characters. Her karyotype is 46XX. FSH is 5 and LH is 13. What is the likely diagnosis? (INICET MAY 2024)", "options": [{"label": "A", "text": "Gonadal dysgenesis", "correct": false}, {"label": "B", "text": "Mullerian agenesis", "correct": true}, {"label": "C", "text": "Kallmann syndrome", "correct": false}, {"label": "D", "text": "Androgen insensitivity syndrome", "correct": false}], "correct_answer": "B. Mullerian agenesis", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Mullerian agenesis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Mullerian agenesis is a likely diagnosis in a patient with primary amenorrhea, normal secondary sexual development, normal FSH/LH levels, and a 46XX karyotype.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is an absolute contraindication for the insertion of the device shown in the image below? (NEET PG 2022)", "options": [{"label": "A", "text": "Menstruation", "correct": false}, {"label": "B", "text": "ï»¿ï»¿ï»¿Trophoblastic disease", "correct": true}, {"label": "C", "text": "ï»¿ï»¿ï»¿Immediately after delivery", "correct": false}, {"label": "D", "text": "ï»¿ï»¿ï»¿Ruptured condom during intercourse", "correct": false}], "correct_answer": "B. ï»¿ï»¿ï»¿Trophoblastic disease", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/untitled-80.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. B) Trophoblastic disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The given image shows a copper-containing IUCD (intrauterine contraceptive device). ABSOLUTE c/I to an Intra-uterine device are: Unexplained uterine or vaginal bleeding Post abortal sepsis/ Puerperal sepsis/ Current Pelvic inflammatory/ disease, Genital Tuberculosis Cancers: Endometrial cancer, Cervical cancer, Gestational trophoblastic neoplasia Large fibroid distorting the uterine cavity, Mullerian anomalies distorting the uterine cavity</li><li>â€¢ The given image shows a copper-containing IUCD (intrauterine contraceptive device).</li><li>â€¢ ABSOLUTE c/I to an Intra-uterine device are: Unexplained uterine or vaginal bleeding Post abortal sepsis/ Puerperal sepsis/ Current Pelvic inflammatory/ disease, Genital Tuberculosis Cancers: Endometrial cancer, Cervical cancer, Gestational trophoblastic neoplasia Large fibroid distorting the uterine cavity, Mullerian anomalies distorting the uterine cavity</li><li>â€¢ Unexplained uterine or vaginal bleeding Post abortal sepsis/ Puerperal sepsis/ Current Pelvic inflammatory/ disease, Genital Tuberculosis Cancers: Endometrial cancer, Cervical cancer, Gestational trophoblastic neoplasia Large fibroid distorting the uterine cavity, Mullerian anomalies distorting the uterine cavity</li><li>â€¢ Unexplained uterine or vaginal bleeding</li><li>â€¢ Post abortal sepsis/ Puerperal sepsis/ Current Pelvic inflammatory/ disease, Genital Tuberculosis</li><li>â€¢ Cancers: Endometrial cancer, Cervical cancer, Gestational trophoblastic neoplasia</li><li>â€¢ Large fibroid distorting the uterine cavity, Mullerian anomalies distorting the uterine cavity</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Menstruation : Intra-uterine device can be inserted even during periods although preferably it should be inserted post-menstrual</li><li>â€¢ Option A. Menstruation</li><li>â€¢ Option C. Immediately after delivery : This is called as Post placental IUCD insertion (within 10 mins of placental delivery)</li><li>â€¢ Option C. Immediately after delivery</li><li>â€¢ Option D. Ruptured condom during intercourse : Following a ruptured condom, CUT can be inserted as an emergency contraception</li><li>â€¢ Option D. Ruptured condom during intercourse</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Trophoblastic disease is an ABSOLUTE c/I to an Intra-uterine device.</li><li>âž¤ Trophoblastic disease is an</li><li>âž¤ Ref: https://www.who.int/publications/i/item/9789241549158</li><li>âž¤ Ref:</li><li>âž¤ https://www.who.int/publications/i/item/9789241549158</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "What is the ideal time for nuchal translucency evaluation? (NEET PG 2019)", "options": [{"label": "A", "text": "6-8 weeks", "correct": false}, {"label": "B", "text": "11-14 weeks", "correct": true}, {"label": "C", "text": "14-16 weeks", "correct": false}, {"label": "D", "text": "16-20 weeks", "correct": false}], "correct_answer": "B. 11-14 weeks", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-77.jpg"], "explanation": "<p><strong>Ans. B) 11-14 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ Nuchal Translucency (NT):</li><li>â€¢ Nuchal Translucency (NT):</li><li>â€¢ Definition: Nuchal translucency refers to the maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. Significance: An increased NT measurement is associated with an increased risk for fetal aneuploidy (such as Down syndrome) and various structural anomalies including cardiovascular defects, hydrops fetalis, and cystic hygroma.</li><li>â€¢ Definition: Nuchal translucency refers to the maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>â€¢ Definition:</li><li>â€¢ Significance: An increased NT measurement is associated with an increased risk for fetal aneuploidy (such as Down syndrome) and various structural anomalies including cardiovascular defects, hydrops fetalis, and cystic hygroma.</li><li>â€¢ Significance:</li><li>â€¢ Timing:</li><li>â€¢ Timing:</li><li>â€¢ NT is measured between 11 weeks and 13 weeks 6 days (or 11-14 weeks ) of gestation. This time frame is critical as it ensures the accuracy of the measurement and its correlation with potential anomalies.</li><li>â€¢ NT is measured between 11 weeks and 13 weeks 6 days (or 11-14 weeks ) of gestation. This time frame is critical as it ensures the accuracy of the measurement and its correlation with potential anomalies.</li><li>â€¢ 11 weeks</li><li>â€¢ 13 weeks 6 days</li><li>â€¢ 11-14 weeks</li><li>â€¢ Measurement Criteria:</li><li>â€¢ Measurement Criteria:</li><li>â€¢ Crown-Rump Length (CRL): Should be between 45-84 mm. Fetal Position: Fetus should be in the mid-sagittal plane and in a neutral position. Image Quality: The image must be magnified, and the widest space should be measured. Caliper Placement: The â€˜+â€™ calipers must be placed on the inner borders of the nuchal space, ensuring the amnion is seen separately.</li><li>â€¢ Crown-Rump Length (CRL): Should be between 45-84 mm.</li><li>â€¢ Crown-Rump Length (CRL):</li><li>â€¢ Fetal Position: Fetus should be in the mid-sagittal plane and in a neutral position.</li><li>â€¢ Fetal Position:</li><li>â€¢ Image Quality: The image must be magnified, and the widest space should be measured.</li><li>â€¢ Image Quality:</li><li>â€¢ Caliper Placement: The â€˜+â€™ calipers must be placed on the inner borders of the nuchal space, ensuring the amnion is seen separately.</li><li>â€¢ Caliper Placement:</li><li>â€¢ Screening Efficiency:</li><li>â€¢ Screening Efficiency:</li><li>â€¢ NT Alone: Provides a 65% detection rate for Down syndrome. Combined Test: When combined with the Dual Marker test (beta hCG and PAPP-A), the detection rate for Down syndrome improves to 80%.</li><li>â€¢ NT Alone: Provides a 65% detection rate for Down syndrome.</li><li>â€¢ NT Alone:</li><li>â€¢ Combined Test: When combined with the Dual Marker test (beta hCG and PAPP-A), the detection rate for Down syndrome improves to 80%.</li><li>â€¢ Combined Test:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. 6-8 weeks: This is too early for accurate NT measurement.</li><li>â€¢ Option A. 6-8 weeks:</li><li>â€¢ Option C. 14-16 weeks: This is beyond the optimal time frame for NT evaluation, reducing the effectiveness of the screening.</li><li>â€¢ Option C. 14-16 weeks:</li><li>â€¢ Option D. 16-20 weeks: This period is too late for NT measurement, which should be performed in the first trimester.</li><li>â€¢ Option D. 16-20 weeks:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The ideal time for nuchal translucency evaluation is between 11-14 weeks of gestation.</li><li>âž¤ Ref: Page no 860, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 860, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 52-year-old woman presents with foul-smelling bloody discharge per vagina mixed with mucous discharge. On examination, a necrotizing growth is seen in the cervix with lateral parametrium involvement. What will be the management for this patient? (NEET PG 2023)", "options": [{"label": "A", "text": "Chemotherapy", "correct": false}, {"label": "B", "text": "Brachytherapy", "correct": false}, {"label": "C", "text": "Chemoradiation", "correct": true}, {"label": "D", "text": "Surgery", "correct": false}], "correct_answer": "C. Chemoradiation", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-180546.png", "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210146.jpg"], "explanation": "<p><strong>Ans. C) Chemoradiation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The patient presents with a foul-smelling bloody discharge mixed with mucous discharge, and a necrotizing growth in the cervix with lateral parametrium involvement. These clinical features are suggestive of advanced cervical cancer. The involvement of the lateral parametrium indicates that the cancer has spread beyond the cervix to the surrounding tissues but not to the pelvic wall or the lower third of the vagina, which classifies it as Stage 2B cervical cancer. The standard treatment for Stage 2B cervical cancer is chemoradiation, which combines chemotherapy with radiation therapy. This approach aims to enhance the effectiveness of the treatment, reduce tumor size, and prevent further spread of the cancer.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Chemotherapy: Chemotherapy alone is not the standard treatment for Stage 2B cervical cancer. It may be used in conjunction with radiation, but not as a sole therapy in this stage.</li><li>â€¢ Option A. Chemotherapy:</li><li>â€¢ Option B. Brachytherapy: Brachytherapy, a form of internal radiation therapy, is typically used for early-stage cervical cancer or in combination with external beam radiation therapy for more advanced stages. However, it is not sufficient as a standalone treatment for Stage 2B.</li><li>â€¢ Option B. Brachytherapy:</li><li>â€¢ Option D. Surgery: Surgery is generally not recommended for Stage 2B cervical cancer due to the extent of the disease spread to the parametrium. The preferred approach is chemoradiation to address both local and regional disease.</li><li>â€¢ Option D. Surgery:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Stage 2B cervical cancer, characterized by lateral parametrium involvement, is best managed with chemoradiation.</li><li>âž¤ Staging of CA Cervix</li><li>âž¤ TREATMENT</li><li>âž¤ Surgery: for early stages like stage 1, stage 2A1 Radiotherapy: for all patients from Stage 1 to 4</li><li>âž¤ Surgery: for early stages like stage 1, stage 2A1</li><li>âž¤ Radiotherapy: for all patients from Stage 1 to 4</li><li>âž¤ Chemoradiation can be offered at all stages</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A couple with 2 children who are not able to conceive for over an year now present to the OPD. The male partner is diagnosed to be having hypogonadotrophic hypogonadism. Which of the following is not true? (INICET MAY 2017)", "options": [{"label": "A", "text": "Low LH and FSH", "correct": false}, {"label": "B", "text": "Low testosterone", "correct": false}, {"label": "C", "text": "Oligospermia", "correct": false}, {"label": "D", "text": "Low prolactin levels", "correct": true}], "correct_answer": "D. Low prolactin levels", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Low prolactin levels</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Hypogonadotropic hypogonadism in males is characterized by a deficiency of gonadotropins (LH and FSH), which leads to low testosterone levels and impaired spermatogenesis. This condition often results in oligospermia or azoospermia, contributing to infertility. Additionally, hypogonadotropic hypogonadism is frequently associated with hyperprolactinemia rather than low prolactin levels.</li><li>â€¢ Low LH and FSH: Hypogonadotropic hypogonadism is marked by low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) due to inadequate secretion from the pituitary gland. Low testosterone: The low levels of LH lead to reduced stimulation of Leydig cells in the testes, resulting in low testosterone levels. Oligospermia: The low levels of FSH result in impaired spermatogenesis, often leading to oligospermia or azoospermia. Low prolactin levels (Incorrect): Hypogonadotropic hypogonadism is associated with hyperprolactinemia, not low prolactin levels. Elevated prolactin can inhibit the secretion of gonadotropins, further exacerbating the condition.</li><li>â€¢ Low LH and FSH: Hypogonadotropic hypogonadism is marked by low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) due to inadequate secretion from the pituitary gland.</li><li>â€¢ Low LH and FSH:</li><li>â€¢ Low testosterone: The low levels of LH lead to reduced stimulation of Leydig cells in the testes, resulting in low testosterone levels.</li><li>â€¢ Low testosterone:</li><li>â€¢ Oligospermia: The low levels of FSH result in impaired spermatogenesis, often leading to oligospermia or azoospermia.</li><li>â€¢ Oligospermia:</li><li>â€¢ Low prolactin levels (Incorrect): Hypogonadotropic hypogonadism is associated with hyperprolactinemia, not low prolactin levels. Elevated prolactin can inhibit the secretion of gonadotropins, further exacerbating the condition.</li><li>â€¢ Low prolactin levels (Incorrect):</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Low LH and FSH: True. Gonadotropin deficiency is a hallmark of hypogonadotropic hypogonadism.</li><li>â€¢ Option A. Low LH and FSH:</li><li>â€¢ Option B. Low testosterone: True. The deficiency in LH leads to low testosterone production.</li><li>â€¢ Option B. Low testosterone:</li><li>â€¢ Option C. Oligospermia: True. The deficiency in FSH leads to impaired spermatogenesis, causing oligospermia or azoospermia.</li><li>â€¢ Option C. Oligospermia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ A male with hypogonadotropic hypogonadism will have high prolactin levels, low gonadotropins (LH and FSH), low testosterone, and often oligospermia or azoospermia.</li><li>âž¤ Ref: Page no 199, DC Duttaâ€™s Textbook of Gynecology 8 th edition</li><li>âž¤ Ref: Page no 199, DC Duttaâ€™s Textbook of Gynecology 8 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A woman presents with amenorrhea and a history of frequent abortions. FSH is 7. hCG is < 5. What is the cause of amenorrhea? (FMGE JULY 2023)", "options": [{"label": "A", "text": "Pituitary disorder", "correct": false}, {"label": "B", "text": "Ovarian disorder", "correct": false}, {"label": "C", "text": "Uterine disorder", "correct": true}, {"label": "D", "text": "Adrenal disorder", "correct": false}], "correct_answer": "C. Uterine disorder", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ A normal hormonal profile with amenorrhea and a history of frequent abortions suggests a uterine disorder, such as Asherman syndrome, where intrauterine adhesions disrupt the normal menstrual cycle.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 76-year-old female presented with a non-healing ulcer on the labia majora for a period of 6 months, measuring 2 cm x 3 cm. No lymph nodes were palpable. Biopsy shows squamous cell carcinoma. How do you manage this case? (INICET NOV 2018)", "options": [{"label": "A", "text": "Radical vulvectomy with unilateral LN dissection", "correct": false}, {"label": "B", "text": "Radical vulvectomy with bilateral LN dissection", "correct": true}, {"label": "C", "text": "Simple vulvectomy", "correct": false}, {"label": "D", "text": "Chemoradiation with resection", "correct": false}], "correct_answer": "B. Radical vulvectomy with bilateral LN dissection", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Radical vulvectomy with bilateral LN dissection</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ This patient has a midline lesion on the labia majora, which indicates that the lesion is close to or crossing the midline. In cases of midline lesions or lesions within 2 cm of the midline, bilateral inguinofemoral lymph node dissection is necessary along with radical vulvectomy. This approach ensures that all potential pathways of lymphatic spread are adequately addressed.</li><li>â€¢ New (2021) FIGO staging for carcinoma of the vulva:</li><li>â€¢ New (2021) FIGO staging for carcinoma of the vulva:</li><li>â€¢ Tumors 2 cm or less in size with 1 mm or less invasion: Treated by wide local excision. Tumors more than 2 cm with more than 1 mm depth of invasion: Treated by modified radical vulvectomy with groin lymph node dissection. LN dissection through separate incision: Lymph node dissection should be inguino-femoral. Bilateral lymph node dissection: Performed for midline lesions and those within 2 cm of the midline. Unilateral dissection: If the lesion is unilateral and ipsilateral nodes are negative, bilateral dissection is not necessary.</li><li>â€¢ Tumors 2 cm or less in size with 1 mm or less invasion: Treated by wide local excision.</li><li>â€¢ Tumors 2 cm or less in size with 1 mm or less invasion:</li><li>â€¢ Tumors more than 2 cm with more than 1 mm depth of invasion: Treated by modified radical vulvectomy with groin lymph node dissection.</li><li>â€¢ Tumors more than 2 cm with more than 1 mm depth of invasion:</li><li>â€¢ LN dissection through separate incision: Lymph node dissection should be inguino-femoral.</li><li>â€¢ LN dissection through separate incision:</li><li>â€¢ Bilateral lymph node dissection: Performed for midline lesions and those within 2 cm of the midline.</li><li>â€¢ Bilateral lymph node dissection:</li><li>â€¢ Unilateral dissection: If the lesion is unilateral and ipsilateral nodes are negative, bilateral dissection is not necessary.</li><li>â€¢ Unilateral dissection:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Radical vulvectomy with unilateral LN dissection: This would be appropriate for unilateral lesions with no evidence of contralateral spread, but not for midline lesions.</li><li>â€¢ Option A. Radical vulvectomy with unilateral LN dissection:</li><li>â€¢ Option C. Simple vulvectomy: Simple vulvectomy is not sufficient for managing invasive squamous cell carcinoma with a lesion size of 2 cm x 3 cm and potential for deeper invasion.</li><li>â€¢ Option C. Simple vulvectomy:</li><li>â€¢ Option D. Chemoradiation with resection: Chemoradiation followed by resection is typically reserved for advanced or inoperable cases, or where there is a need to downstage the tumor before surgery. This case can be managed surgically given the size and lack of palpable lymph nodes.</li><li>â€¢ Option D. Chemoradiation with resection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ For midline lesions or lesions within 2 cm of the midline in squamous cell carcinoma of the vulva, radical vulvectomy with bilateral inguinofemoral lymph node dissection is the appropriate management.</li><li>âž¤ Ref: FIGO staging of CA vulva, Berek and Novakâ€™s gynecology 15 th edition pg 1436, Williamâ€™s textbook of gynecology 3rd edition pg 484-485.</li><li>âž¤ Ref: FIGO staging of CA vulva, Berek and Novakâ€™s gynecology 15 th edition pg 1436, Williamâ€™s textbook of gynecology 3rd edition pg 484-485.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "What is the dose of Ulipristal used in emergency contraception? (NEET PG 2019)", "options": [{"label": "A", "text": "30 mg", "correct": true}, {"label": "B", "text": "300 mg", "correct": false}, {"label": "C", "text": "60 mg", "correct": false}, {"label": "D", "text": "600 mg", "correct": false}], "correct_answer": "A. 30 mg", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-76.jpg"], "explanation": "<p><strong>Ans. A) 30 mg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The dose of Ulipristal in emergency contraception is 30 mg to be taken within 72 hrs (can be taken upto 120hrs).</li><li>â€¢ The following can be used as emergency contraceptives:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The dose of Ulipristal for emergency contraception is 30 mg, to be taken within 72 hours (up to 120 hours) after unprotected intercourse.</li><li>âž¤ Ref: Page no 630, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li><li>âž¤ Ref: Page no 630, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The ideal number of ANC visits is: (FMGE JULY 2024)", "options": [{"label": "A", "text": "4", "correct": false}, {"label": "B", "text": "8", "correct": false}, {"label": "C", "text": "10", "correct": false}, {"label": "D", "text": "12-15", "correct": true}], "correct_answer": "D. 12-15", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans.Â D) 12-15</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The ideal number of ANC visits is 12-15, as recommended by American guidelines, to ensure comprehensive prenatal care.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "What does this Cardio-Tocography show? (INICET MAY 2019)", "options": [{"label": "A", "text": "Deceleration", "correct": true}, {"label": "B", "text": "ï»¿ï»¿ï»¿Acceleration", "correct": false}, {"label": "C", "text": "ï»¿ï»¿ï»¿Normal", "correct": false}, {"label": "D", "text": "ï»¿ï»¿ï»¿Deceleration followed by acceleration", "correct": false}], "correct_answer": "A. Deceleration", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_LB2EmwO.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. A) Deceleration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The Cardio-Tocography (CTG) in question shows decelerations, which are characterized by a drop in the fetal heart rate (FHR) by at least 15 beats per minute (bpm) lasting for at least 15 seconds.</li><li>â€¢ Types of Decelerations on CTG:</li><li>â€¢ Types of Decelerations on CTG:</li><li>â€¢ Early Deceleration: The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction. Caused by head compression during contractions. Commonly observed in the second stage of labor. Late Deceleration: The nadir of the deceleration occurs after the peak of the contraction. Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia. Considered an ominous sign and requires prompt evaluation and intervention. Variable Deceleration: There is no fixed relationship between the deceleration and uterine contractions. Caused by umbilical cord compression, often seen with oligohydramnios. Significant if persistent, with FHR <70 bpm for more than 60 seconds. Prolonged Deceleration: Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes. May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</li><li>â€¢ Early Deceleration: The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction. Caused by head compression during contractions. Commonly observed in the second stage of labor.</li><li>â€¢ Early Deceleration:</li><li>â€¢ The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction. Caused by head compression during contractions. Commonly observed in the second stage of labor.</li><li>â€¢ The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction.</li><li>â€¢ Caused by head compression during contractions.</li><li>â€¢ Commonly observed in the second stage of labor.</li><li>â€¢ Late Deceleration: The nadir of the deceleration occurs after the peak of the contraction. Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia. Considered an ominous sign and requires prompt evaluation and intervention.</li><li>â€¢ Late Deceleration:</li><li>â€¢ The nadir of the deceleration occurs after the peak of the contraction. Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia. Considered an ominous sign and requires prompt evaluation and intervention.</li><li>â€¢ The nadir of the deceleration occurs after the peak of the contraction.</li><li>â€¢ Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia.</li><li>â€¢ Considered an ominous sign and requires prompt evaluation and intervention.</li><li>â€¢ Variable Deceleration: There is no fixed relationship between the deceleration and uterine contractions. Caused by umbilical cord compression, often seen with oligohydramnios. Significant if persistent, with FHR <70 bpm for more than 60 seconds.</li><li>â€¢ Variable Deceleration:</li><li>â€¢ There is no fixed relationship between the deceleration and uterine contractions. Caused by umbilical cord compression, often seen with oligohydramnios. Significant if persistent, with FHR <70 bpm for more than 60 seconds.</li><li>â€¢ There is no fixed relationship between the deceleration and uterine contractions.</li><li>â€¢ Caused by umbilical cord compression, often seen with oligohydramnios.</li><li>â€¢ Significant if persistent, with FHR <70 bpm for more than 60 seconds.</li><li>â€¢ Prolonged Deceleration: Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes. May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</li><li>â€¢ Prolonged Deceleration:</li><li>â€¢ Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes. May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</li><li>â€¢ Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes.</li><li>â€¢ May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Acceleration: This would show an increase in the fetal heart rate by at least 15 bpm lasting for at least 15 seconds, which is not the case here.</li><li>â€¢ Option B. Acceleration:</li><li>â€¢ Option C. Normal: A normal CTG would not show any decelerations or would show a typical pattern of fetal heart rate variability and accelerations.</li><li>â€¢ Option C. Normal:</li><li>â€¢ Option D. Deceleration followed by acceleration: This pattern would indicate a combination of deceleration and acceleration, which is not specified here.</li><li>â€¢ Option D. Deceleration followed by acceleration:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Decelerations on a Cardio-Tocography indicate a decrease in fetal heart rate by at least 15 bpm lasting for at least 15 seconds, with different types signifying various conditions and levels of concern.</li><li>âž¤ Ref: Page no 994, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 994, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 33-week multigravida woman presents with epigastric pain, headache, visual symptoms, proteinuria: 3+. The next step of management would be? (INICET NOV 2019)", "options": [{"label": "A", "text": "Immediate C- section", "correct": false}, {"label": "B", "text": "Dexamethasone for fetal lung maturity", "correct": false}, {"label": "C", "text": "Induction - vaginal delivery", "correct": false}, {"label": "D", "text": "MgSO4 IV", "correct": true}], "correct_answer": "D. MgSO4 IV", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) MgSO4 IV</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ MgSO4 is recommended for neuro-prophylaxis in women with severe or imminent eclampsia to prevent seizures.</li><li>âž¤ Ref: Williamâ€™s textbook of obstetrics 26 th edition pg 1840</li><li>âž¤ Ref: Williamâ€™s textbook of obstetrics 26 th edition pg 1840</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A primigravida is in the 2nd stage of labor for 2 hours. The head is at +3 with caput present and the fetal heart rate (FHR) is dropping to 90 bpm. What is the best way to deliver the head? (INICET MAY 2024)", "options": [{"label": "A", "text": "Mid cavity forceps", "correct": false}, {"label": "B", "text": "Low forceps", "correct": false}, {"label": "C", "text": "Outlet forceps", "correct": true}, {"label": "D", "text": "Ventouse", "correct": false}], "correct_answer": "C. Outlet forceps", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Outlet forceps</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In cases of fetal distress with the fetal head at +3 station, outlet forceps are the preferred method of assisted delivery due to their speed and effectiveness, particularly when caput is present.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following statements regarding MgSO 4 is false? (INICET MAY 2022)", "options": [{"label": "A", "text": "MgSO 4 causes uterine relaxation, but is dose dependent", "correct": false}, {"label": "B", "text": "MgSO 4 is continued upto 24 hours after delivery or last attack of seizure", "correct": false}, {"label": "C", "text": "It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP", "correct": true}, {"label": "D", "text": "In renal failure, MgSO4 loading dose can be given, but maintenance dose should be adjusted based on renal function", "correct": false}], "correct_answer": "C. It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ MgSO4 is used for preventing seizures in eclampsia and causes uterine relaxation but does not lower blood pressure.</li><li>âž¤ Ref: Page no 1867, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 1867, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "For emergency contraception, a single tab of 0.75 mg of LNG was taken, it should be followed by which of the following? (INICET NOV 2017)", "options": [{"label": "A", "text": "Single dose of 0.75 after 12 hrs", "correct": true}, {"label": "B", "text": "Two doses 12 hrs apart", "correct": false}, {"label": "C", "text": "Three doses 12 hrs apart", "correct": false}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "A. Single dose of 0.75 after 12 hrs", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-094530.png"], "explanation": "<p><strong>Ans. A) Single dose of 0.75 after 12 hrs</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ In this case, the 2nd dose of LNG 0.75 mg (levonorgestrel) is taken after 12 hours. One tablet of LNG 0.75mg should be taken within 72 hours of unprotected intercourse and another 12 hours later. Alternately, two tablets (of 0.75mg) or a single 1.5mg tablet can be taken as a single dose. The tablets can be offered up to 72h of an act of unprotected intercourse, but the efficacy decreases with the longer coital-drug interval.</li><li>â€¢ In this case, the 2nd dose of LNG 0.75 mg (levonorgestrel) is taken after 12 hours.</li><li>â€¢ One tablet of LNG 0.75mg should be taken within 72 hours of unprotected intercourse and another 12 hours later.</li><li>â€¢ Alternately, two tablets (of 0.75mg) or a single 1.5mg tablet can be taken as a single dose.</li><li>â€¢ The tablets can be offered up to 72h of an act of unprotected intercourse, but the efficacy decreases with the longer coital-drug interval.</li><li>â€¢ Other emergency contraceptives available:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Emergency contraception using levonorgestrel requires a follow-up dose of 0.75 mg taken 12 hours after the initial dose to ensure efficacy.</li><li>âž¤ Ref: Page no 243, Berek and Novakâ€™s Gynecology 15 th edition</li><li>âž¤ Ref: Page no 243, Berek and Novakâ€™s Gynecology 15 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not a contraindication for the induction of labor? (NEET PG 2019)", "options": [{"label": "A", "text": "Pelvic tumor", "correct": false}, {"label": "B", "text": "Herpes infection", "correct": false}, {"label": "C", "text": "Heart disease", "correct": true}, {"label": "D", "text": "History of lower transverse cesarean section in last two pregnancies", "correct": false}], "correct_answer": "C. Heart disease", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Heart disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Cardiovascular diseases are not a contraindication for vaginal delivery. In fact, NVD is preferred in heart disease patients. The second stage of labour is cut short with the use of instrumental vaginal delivery like forceps or ventouse assisted vaginal delivery.</li><li>â€¢ Cardiovascular diseases are not a contraindication for vaginal delivery. In fact, NVD is preferred in heart disease patients. The second stage of labour is cut short with the use of instrumental vaginal delivery like forceps or ventouse assisted vaginal delivery.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Pelvic tumor : Pelvic tumor if diagnosed may interfere with normal labor and needs to be evaluated before deciding the mode of delivery</li><li>â€¢ Option A. Pelvic tumor</li><li>â€¢ Option B. Herpes infection :  Active herpes is an absolute contra-indication to a normal delivery due to the high viral shedding in the lesions and increased risk of neonatal herpes.</li><li>â€¢ Option B. Herpes infection</li><li>â€¢ Option D. History of lower transverse cesarean section in last two pregnancies : History of 2 or more previous cesareans is also a contra-indication to a vaginal delivery and hence induction is not done</li><li>â€¢ Option D. History of lower transverse cesarean section in last two pregnancies</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Cardiovascular diseases are not a contraindication for vaginal delivery, and NVD is preferred in heart disease patients.</li><li>âž¤ Cardiovascular diseases are not a contraindication for vaginal delivery, and NVD is preferred in heart disease patients.</li><li>âž¤ Ref: Page no 332, Dc Duttaâ€™s Textbook of Obstetrics 8 th edition</li><li>âž¤ Ref: Page no 332, Dc Duttaâ€™s Textbook of Obstetrics 8 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All are true regarding peripartum cardiomyopathy except? (NEET PG 2018)", "options": [{"label": "A", "text": "Development of cardiac failure within 5 months of delivery", "correct": false}, {"label": "B", "text": "Left ventricular diastolic dysfunction", "correct": true}, {"label": "C", "text": "Absence of identifiable cause", "correct": false}, {"label": "D", "text": "Dilated left ventricle", "correct": false}], "correct_answer": "B. Left ventricular diastolic dysfunction", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Left ventricular diastolic dysfunction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Peripartum cardiomyopathy (PPCM) is a form of heart failure that occurs during the last month of pregnancy or within five months postpartum. It is characterized by left ventricular systolic dysfunction, rather than diastolic dysfunction. The diagnostic criteria for PPCM include:</li><li>â€¢ Cardiac failure developing in the last month of pregnancy or within five months after delivery. Absence of an identifiable cause for the cardiac failure. Absence of recognizable heart disease prior to the last month of pregnancy. Echocardiographic evidence of left ventricular systolic dysfunction (ejection fraction <45% or fractional shortening <30%) along with a dilated left ventricle.</li><li>â€¢ Cardiac failure developing in the last month of pregnancy or within five months after delivery.</li><li>â€¢ Absence of an identifiable cause for the cardiac failure.</li><li>â€¢ Absence of recognizable heart disease prior to the last month of pregnancy.</li><li>â€¢ Echocardiographic evidence of left ventricular systolic dysfunction (ejection fraction <45% or fractional shortening <30%) along with a dilated left ventricle.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Development of cardiac failure within 5 months of delivery : Correct. PPCM develops within five months of delivery.</li><li>â€¢ Option A. Development of cardiac failure within 5 months of delivery</li><li>â€¢ Option C. Absence of identifiable cause : Correct. PPCM is diagnosed in the absence of an identifiable cause for cardiac failure.</li><li>â€¢ Option C. Absence of identifiable cause</li><li>â€¢ Option D. Dilated left ventricle : Correct. PPCM is associated with a dilated left ventricle.</li><li>â€¢ Option D. Dilated left ventricle</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Peripartum cardiomyopathy is characterized by left ventricular systolic dysfunction and occurs within the last month of pregnancy or up to five months postpartum, in the absence of an identifiable cause for cardiac failure.</li><li>âž¤ Ref: https://www.ncbi.nlm.nih.gov/books/NBK482185/</li><li>âž¤ Ref: https://www.ncbi.nlm.nih.gov/books/NBK482185/</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A pregnant lady at 20 weeks of gestation comes with complaints of acute onset fever, and pain in the right lumbar region. It is associated with chills, nausea, and vomiting. Urinalysis reveals the presence of E. coli and a diagnosis of acute pyelonephritis is made. Which of the following is incorrect regarding the management of acute pyelonephritis in pregnancy? (INICET MAY 2022)", "options": [{"label": "A", "text": "Hospitalize, send urine and blood cultures and start on antibiotics.", "correct": false}, {"label": "B", "text": "Oral antibiotics once afebrile", "correct": false}, {"label": "C", "text": "Maintain urine output > 50 ml/h; Intravenous crystalloids can be given", "correct": false}, {"label": "D", "text": "Discharge if afebrile for 72 h; Continue antibiotics for 5 days", "correct": true}], "correct_answer": "D. Discharge if afebrile for 72 h; Continue antibiotics for 5 days", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Discharge if afebrile for 72 h; Continue antibiotics for 5 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The management of acute pyelonephritis during pregnancy involves several key steps to ensure effective treatment and prevent complications:</li><li>â€¢ Hospitalization: Necessary for intravenous antibiotics and monitoring. Urine and Blood Cultures: Essential for identifying the pathogen and tailoring antibiotic therapy. Intravenous Crystalloids: Used to maintain adequate urine output (â‰¥50 mL/h) and ensure proper hydration. Antibiotics: Initially given intravenously, with the switch to oral antibiotics once the patient is afebrile.</li><li>â€¢ Hospitalization: Necessary for intravenous antibiotics and monitoring.</li><li>â€¢ Hospitalization:</li><li>â€¢ Urine and Blood Cultures: Essential for identifying the pathogen and tailoring antibiotic therapy.</li><li>â€¢ Urine and Blood Cultures:</li><li>â€¢ Intravenous Crystalloids: Used to maintain adequate urine output (â‰¥50 mL/h) and ensure proper hydration.</li><li>â€¢ Intravenous Crystalloids:</li><li>â€¢ Antibiotics: Initially given intravenously, with the switch to oral antibiotics once the patient is afebrile.</li><li>â€¢ Antibiotics:</li><li>â€¢ The incorrect statement is Option D . The correct management protocol dictates:</li><li>â€¢ Option D</li><li>â€¢ Discharge Criteria: The patient can be discharged once afebrile for 24 hours , not 72 hours. Duration of Antibiotics: The recommended course of antibiotics is 7 to 10 days , not just 5 days.</li><li>â€¢ Discharge Criteria: The patient can be discharged once afebrile for 24 hours , not 72 hours.</li><li>â€¢ Discharge Criteria:</li><li>â€¢ 24 hours</li><li>â€¢ Duration of Antibiotics: The recommended course of antibiotics is 7 to 10 days , not just 5 days.</li><li>â€¢ Duration of Antibiotics:</li><li>â€¢ 7 to 10 days</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Hospitalize, send urine and blood cultures and start on antibiotics: Correct. Hospitalization, urine and blood cultures, and starting antibiotics are all appropriate steps in managing acute pyelonephritis.</li><li>â€¢ Option A. Hospitalize, send urine and blood cultures and start on antibiotics:</li><li>â€¢ Option B. Oral antibiotics once afebrile: Correct. Switching to oral antibiotics is appropriate once the patient is afebrile.</li><li>â€¢ Option B.</li><li>â€¢ Oral antibiotics once afebrile:</li><li>â€¢ Option C. Maintain urine output > 50 ml/h; Intravenous crystalloids can be given: Correct. Maintaining a urine output of > 50 mL/h and using intravenous crystalloids are standard practices to manage hydration and ensure adequate renal function.</li><li>â€¢ Option C. Maintain urine output > 50 ml/h; Intravenous crystalloids can be given:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Discharge from the hospital should be considered once the patient is afebrile for 24 hours, and antibiotics should be continued for 7 to 10 days in cases of acute pyelonephritis in pregnancy.</li><li>âž¤ Ref: Page no 2594, Williams Obstetrics, 26 th edition</li><li>âž¤ Ref: Page no 2594, Williams Obstetrics, 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following patients would be classified as having primary amenorrhea? (INICET NOV 2022)", "options": [{"label": "A", "text": "11-year-old girl with Tanner stage 1 breasts", "correct": false}, {"label": "B", "text": "14-year-old girl with Tanner stage 1 breasts", "correct": true}, {"label": "C", "text": "13-year-old girl with Tanner stage 5 breasts", "correct": false}, {"label": "D", "text": "12-year-old with Tanner stage 4 breasts", "correct": false}], "correct_answer": "B. 14-year-old girl with Tanner stage 1 breasts", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) 14-year-old girl with Tanner stage 1 breasts</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Primary amenorrhea is defined as the absence of menstruation by age 13 without secondary sexual characteristics or by age 15 with secondary sexual characteristics.</li><li>âž¤ Ref: ACOG Committee opinion menstruation in girls and adolescents (2015), Speroffâ€™s gynecologic endocrinology 7th edition pg401, Duttaâ€™s textbook of gynecology 6 th edition pg 450</li><li>âž¤ Ref: ACOG Committee opinion menstruation in girls and adolescents (2015), Speroffâ€™s gynecologic endocrinology 7th edition pg401, Duttaâ€™s textbook of gynecology 6 th edition pg 450</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is recommended by the WHO for the management of the second stage of labor? (INICET MAY 2021)", "options": [{"label": "A", "text": "Mandatory episiotomy", "correct": false}, {"label": "B", "text": "Manual perineal support and warm compresses", "correct": true}, {"label": "C", "text": "Maintain head in deflexion and deliver", "correct": false}, {"label": "D", "text": "Deliver in lithotomy position only", "correct": false}], "correct_answer": "B. Manual perineal support and warm compresses", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Manual perineal support and warm compresses</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Manual perineal support and warm compresses are recommended by the WHO to reduce perineal trauma during the second stage of labor.</li><li>âž¤ Ref: https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf</li><li>âž¤ Ref:</li><li>âž¤ https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "At the 5th postnatal day, a woman presents with sadness, irritability, restlessness, and reduced sleep. What is the diagnosis? (FMGE JULY 2023)", "options": [{"label": "A", "text": "Postpartum blues", "correct": true}, {"label": "B", "text": "Postpartum depression", "correct": false}, {"label": "C", "text": "Postpartum anxiety", "correct": false}, {"label": "D", "text": "Postpartum psychosis", "correct": false}], "correct_answer": "A. Postpartum blues", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Postpartum blues</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Postpartum blues, also known as \"baby blues,\" typically occur within the first few days after delivery and can last up to two weeks. It is characterized by mood swings, sadness, irritability, restlessness, and difficulty sleeping. These symptoms are usually mild and self-limiting, resolving on their own with support and reassurance.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Postpartum depression : This condition occurs after the first two weeks post-delivery and can persist for months. It includes more severe symptoms such as persistent sadness, lack of interest in the baby, feelings of hopelessness, and possibly suicidal thoughts.</li><li>â€¢ Option B. Postpartum depression</li><li>â€¢ more severe symptoms</li><li>â€¢ Option C. Postpartum anxiety : This condition involves excessive worry, anxiety, and often includes physical symptoms like palpitations or hyperventilation . It can occur at any time during the postpartum period.</li><li>â€¢ Option C. Postpartum anxiety</li><li>â€¢ palpitations or hyperventilation</li><li>â€¢ Option D. Postpartum psychosis : This is a rare but severe condition that usually occurs within the first few weeks after delivery. It involves symptoms such as hallucinations, delusions, severe agitation, and risk of harm to the mother or baby.</li><li>â€¢ Option D. Postpartum psychosis</li><li>â€¢ severe condition</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Postpartum blues are common in the first few days after delivery and are characterized by sadness, irritability, restlessness, and reduced sleep. The condition is generally mild and self-limiting, resolving with support and care.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not the mechanism of action of progesterone only pills? (NEET PG 2018)", "options": [{"label": "A", "text": "Thicken the cervical mucus", "correct": false}, {"label": "B", "text": "Prevents ovulation", "correct": false}, {"label": "C", "text": "Kills the sperms in the cervical canal", "correct": true}, {"label": "D", "text": "Inhibits penetration of sperm", "correct": false}], "correct_answer": "C. Kills the sperms in the cervical canal", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Kills the sperms in the cervical canal</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Progesterone only pills (POPs), also known as mini pills, act through several mechanisms to prevent pregnancy, but they do not kill sperms in the cervical canal.</li><li>â€¢ Incorrect. Progesterone only pills do not have a spermicidal effect. They do not kill sperm; instead, they work by altering the cervical mucus and preventing ovulation.</li><li>â€¢ The mechanisms of action include:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Thickening the cervical mucus : This makes it difficult for sperm to enter the uterus and fertilize an egg.</li><li>â€¢ Option A. Thickening the cervical mucus</li><li>â€¢ Option B. Preventing ovulation : Although not as consistently as combined oral contraceptives, POPs can inhibit ovulation in some women.</li><li>â€¢ Option B. Preventing ovulation</li><li>â€¢ Option D. Inhibiting penetration of sperm : By thickening the cervical mucus and affecting the endometrial lining, POPs inhibit the spermâ€™s ability to penetrate and fertilize an egg.</li><li>â€¢ Option D. Inhibiting penetration of sperm</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Progesterone only pills prevent pregnancy by thickening cervical mucus, inhibiting ovulation, and preventing sperm penetration, but they do not kill sperm in the cervical canal.</li><li>âž¤ Ref: Page no 323, DC Duttaâ€™s Textbook of Obstetrics 8 th edition</li><li>âž¤ Ref: Page no 323, DC Duttaâ€™s Textbook of Obstetrics 8 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A hypertensive pregnant woman with abdominal pain, bleeding per vaginum, and loss of fetal movements. What is the probable diagnosis? (INICET NOV 2020)", "options": [{"label": "A", "text": "Abruptio placenta", "correct": true}, {"label": "B", "text": "Placenta previa", "correct": false}, {"label": "C", "text": "Hydramnios", "correct": false}, {"label": "D", "text": "Preterm labour", "correct": false}], "correct_answer": "A. Abruptio placenta", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Abruptio placenta</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Abruptio placentae, also known as placental abruption, commonly occurs in hypertensive disorders of pregnancy. It is characterized by the premature separation of the placenta from the uterus, leading to painful vaginal bleeding, abdominal pain, and often fetal distress or fetal death. The uterus may be tonically contracted in such cases.</li><li>â€¢ Key Points:</li><li>â€¢ Key Points:</li><li>â€¢ Hypertensive Disorders: Abruptio placentae is frequently associated with hypertensive disorders of pregnancy. Clinical Presentation: Painful vaginal bleeding, abdominal pain, and loss of fetal movements are hallmark signs. Uterine Contraction: The uterus may feel firm and tender, indicating a tonic contraction.</li><li>â€¢ Hypertensive Disorders: Abruptio placentae is frequently associated with hypertensive disorders of pregnancy.</li><li>â€¢ Hypertensive Disorders:</li><li>â€¢ Clinical Presentation: Painful vaginal bleeding, abdominal pain, and loss of fetal movements are hallmark signs.</li><li>â€¢ Clinical Presentation:</li><li>â€¢ Uterine Contraction: The uterus may feel firm and tender, indicating a tonic contraction.</li><li>â€¢ Uterine Contraction:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Placenta previa: Placenta previa involves painless vaginal bleeding due to the placenta covering the cervix. It generally does not cause decreased fetal movements unless there is severe bleeding leading to maternal and fetal compromise.</li><li>â€¢ Option B. Placenta previa:</li><li>â€¢ Option C. Hydramnios: Hydramnios (polyhydramnios) involves excessive amniotic fluid and does not typically present with bleeding.</li><li>â€¢ Option C. Hydramnios:</li><li>â€¢ Option D. Preterm labor: Preterm labor typically does not present with bleeding and is characterized by regular uterine contractions leading to cervical changes before 37 weeks of gestation. Prematurity in preterm labor is iatrogenic if induced.</li><li>â€¢ Option D. Preterm labor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Abruptio placenta should be suspected in a hypertensive pregnant woman presenting with painful vaginal bleeding, abdominal pain, and loss of fetal movements, as it is commonly associated with hypertensive disorders and presents with these clinical features.</li><li>âž¤ Ref: Williams Textbook of obstetrics 26 th edition pg 1944</li><li>âž¤ Ref: Williams Textbook of obstetrics 26 th edition pg 1944</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following decreases in pregnancy? (NEET PG 2019)", "options": [{"label": "A", "text": "Respiratory rate", "correct": false}, {"label": "B", "text": "Vital capacity", "correct": false}, {"label": "C", "text": "Functional residual capacity", "correct": true}, {"label": "D", "text": "Inspiratory capacity", "correct": false}], "correct_answer": "C. Functional residual capacity", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-71.jpg"], "explanation": "<p><strong>Ans. C) Functional residual capacity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Functional residual capacity (FRC) is the volume of air remaining in the lungs at the end of a normal expiration. During pregnancy, the diaphragm is elevated due to the enlarging uterus, leading to a decrease in FRC by approximately 22%. This is primarily due to reductions in expiratory reserve volume and residual volume.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Respiratory rate : The respiratory rate typically remains unchanged during pregnancy, staying at about 14-16 breaths per minute.</li><li>â€¢ Option A. Respiratory rate</li><li>â€¢ Option B. Vital capacity : Vital capacity, which is the sum of inspiratory reserve volume, tidal volume, and expiratory reserve volume, remains unchanged during pregnancy.</li><li>â€¢ Option B. Vital capacity</li><li>â€¢ Option D. Inspiratory capacity : Inspiratory capacity increases during pregnancy by about 10%. This increase is due to the higher tidal volume and inspiratory reserve volume.</li><li>â€¢ Option D. Inspiratory capacity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Functional residual capacity decreases during pregnancy due to the elevation of the diaphragm caused by the enlarging uterus.</li><li>âž¤ Functional residual capacity decreases in pregnancy.</li><li>âž¤ Functional residual capacity decreases in pregnancy.</li><li>âž¤ Ref: Page no 189, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 189, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 56-year-old multipara woman presented with grade II/III uterine prolapse with cystocele. She complains of passing urine on coughing and sneezing. What is the type of urinary incontinence seen in this patient? (NEET PG 2021)", "options": [{"label": "A", "text": "Overflow incontinence", "correct": false}, {"label": "B", "text": "Urge incontinence", "correct": false}, {"label": "C", "text": "Stress incontinence", "correct": true}, {"label": "D", "text": "Neurogenic bladder", "correct": false}], "correct_answer": "C. Stress incontinence", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Stress incontinence</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Stress urinary incontinence is characterized by involuntary leakage of urine due to increased intra-abdominal pressure and is commonly seen in women with utero-vaginal prolapse.</li><li>âž¤ Ref: Page no 597, DC Duttaâ€™s Textbook of Gynecology 6 th edition</li><li>âž¤ Ref: Page no 597, DC Duttaâ€™s Textbook of Gynecology 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An 18-year-old girl presents with a history of low-grade fever, weight loss, abdominal pain and amenorrhea for six months. On examination, a pelvic mass is felt on the left side and signs of ascites are positive. What is your diagnosis? (NEET PG 2020)", "options": [{"label": "A", "text": "Tuberculosis with tubo-ovarian mass", "correct": true}, {"label": "B", "text": "Ovarian malignancy", "correct": false}, {"label": "C", "text": "Ectopic pregnancy", "correct": false}, {"label": "D", "text": "Submucous fibroid", "correct": false}], "correct_answer": "A. Tuberculosis with tubo-ovarian mass", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Tuberculosis with tubo-ovarian mass</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ This is the most likely diagnosis in view of the following points Age Symptoms: low grade fever, weight loss, pain and amenorrhoea Adnexal mass with ascites</li><li>â€¢ This is the most likely diagnosis in view of the following points Age Symptoms: low grade fever, weight loss, pain and amenorrhoea Adnexal mass with ascites</li><li>â€¢ Age Symptoms: low grade fever, weight loss, pain and amenorrhoea Adnexal mass with ascites</li><li>â€¢ Age</li><li>â€¢ Symptoms: low grade fever, weight loss, pain and amenorrhoea</li><li>â€¢ Adnexal mass with ascites</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Ovarian malignancy : Ovarian malignancy may present with weight loss, ascites and a pelvic mass. But a young age and amenorrhea do not go in favor of ovarian malignancy</li><li>â€¢ Option B. Ovarian malignancy</li><li>â€¢ Option C. Ectopic pregnancy : Ectopic pregnancy will be an acute presentation and will not present with fever/ weight loss</li><li>â€¢ Option C. Ectopic pregnancy</li><li>â€¢ Option D. Submucous fibroid : Submucous fibroid presents with menorrhagia/ inter-menstrual bleeding and the uterus will be uniformly enlarged. There will not be any pelvic mass.</li><li>â€¢ Option D. Submucous fibroid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Tuberculosis with a tubo-ovarian mass is suspected in young patients presenting with low-grade fever, weight loss, amenorrhea, and a pelvic mass with signs of ascites.</li><li>âž¤ Ref: Page no 141, DC Duttaâ€™s Textbook of Gynecology 6 th edition</li><li>âž¤ Ref: Page no 141, DC Duttaâ€™s Textbook of Gynecology 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Post-partum IUCD insertion can be inserted till? (FMGE JULY 2024)", "options": [{"label": "A", "text": "10 mins", "correct": false}, {"label": "B", "text": "24h", "correct": false}, {"label": "C", "text": "48h", "correct": true}, {"label": "D", "text": "7 days", "correct": false}], "correct_answer": "C. 48h", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) 48h</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Postpartum IUCD can be inserted within 48 hours of delivery or after six weeks postpartum . The period between 48 hours and six weeks is contraindicated for IUCD insertion.</li><li>âž¤ within 48 hours of delivery or after six weeks postpartum</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 57-year-old woman has an endometrial thickness of 14 mm with an adnexal mass. A previous report of endometrial biopsy shows complex endometrial hyperplasia with the presence of atypical cells. What is the likely diagnosis? (FMGE JANUARY 2023)", "options": [{"label": "A", "text": "Metastasis endometrial carcinoma to ovary", "correct": true}, {"label": "B", "text": "Polycystic ovarian disease", "correct": false}, {"label": "C", "text": "Struma Ovarii", "correct": false}, {"label": "D", "text": "Immature ovarian teratoma", "correct": false}], "correct_answer": "A. Metastasis endometrial carcinoma to ovary", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-103858.png"], "explanation": "<p><strong>Ans. A) Metastasis endometrial carcinoma to ovary</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Endometrial thickness > 5 mm in postmenopausal women with bleeding should prompt an endometrial biopsy, especially if complex hyperplasia with atypia is suspected due to the high risk of progression to endometrial carcinoma.</li><li>âž¤ Ref: Dutta Textbook of Gynaecology page 329, 460, 294</li><li>âž¤ Ref: Dutta Textbook of Gynaecology page 329, 460, 294</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 32-year-old married woman who came for the evaluation of infertility was found to have a septum in her uterine cavity. What would be the appropriate management of this case? (NEET PG 2021)", "options": [{"label": "A", "text": "Hysterectomy", "correct": false}, {"label": "B", "text": "Laparoscopy and metroplasty", "correct": false}, {"label": "C", "text": "Hysteroscopy and septoplasty", "correct": true}, {"label": "D", "text": "Laparotomy and metroplasty", "correct": false}], "correct_answer": "C. Hysteroscopy and septoplasty", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/6.jpg"], "explanation": "<p><strong>Ans. C) Hysteroscopy and septoplasty</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Hysteroscopy and septoplasty:</li><li>â€¢ Hysteroscopy and septoplasty:</li><li>â€¢ Uterine septum is a Mullerian anomaly where the uterine cavity is completely or partially separated by a septum. This can lead to infertility, recurrent abortions, preterm labor, fetal growth restriction, malpresentations, and retained placenta. The diagnosis of a uterine septum can be confirmed through hysterosalpingography (HSG), 3D ultrasound, MRI, or hysteroscopy. Hysteroscopy is the gold standard for both diagnosis and treatment. Hysteroscopic resection (septoplasty) is the appropriate management as it involves minimally invasive surgery to remove the septum, which improves reproductive outcomes.</li><li>â€¢ Uterine septum is a Mullerian anomaly where the uterine cavity is completely or partially separated by a septum. This can lead to infertility, recurrent abortions, preterm labor, fetal growth restriction, malpresentations, and retained placenta.</li><li>â€¢ The diagnosis of a uterine septum can be confirmed through hysterosalpingography (HSG), 3D ultrasound, MRI, or hysteroscopy. Hysteroscopy is the gold standard for both diagnosis and treatment.</li><li>â€¢ Hysteroscopic resection (septoplasty) is the appropriate management as it involves minimally invasive surgery to remove the septum, which improves reproductive outcomes.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Hysterectomy: Hysterectomy, the removal of the uterus, is not an appropriate management for a uterine septum in a woman desiring fertility. This would completely eliminate her ability to conceive and carry a pregnancy.</li><li>â€¢ Option A. Hysterectomy:</li><li>â€¢ Option B. Laparoscopy and metroplasty: While laparoscopy can be used to visualize the external uterine anatomy, metroplasty (surgical correction of the uterus) is better performed via hysteroscopy for a uterine septum. Laparoscopy is more invasive and not the first-line approach for this condition.</li><li>â€¢ Option B. Laparoscopy and metroplasty:</li><li>â€¢ Option D. Laparotomy and metroplasty: Laparotomy is an open surgical procedure that involves a larger incision in the abdomen. This approach is unnecessarily invasive for the correction of a uterine septum, which can be effectively managed with a less invasive hysteroscopic approach.</li><li>â€¢ Option D. Laparotomy and metroplasty:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The appropriate management of a uterine septum, especially in a woman seeking fertility, is hysteroscopic resection (septoplasty), which involves minimally invasive surgery to remove the septum and improve reproductive outcomes.</li><li>âž¤ Ref: Page no 47, DC Duttaâ€™s Textbook of Gynecology 6 th edition</li><li>âž¤ Ref: Page no 47, DC Duttaâ€™s Textbook of Gynecology 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A nursing assistant posted in the obstetric care unit was asked to plot a partograph to monitor the progress of labour. After how much dilatation of the cervix, should she start plotting the graph? (INICET MAY 2020)", "options": [{"label": "A", "text": "2cm", "correct": false}, {"label": "B", "text": "4cm", "correct": true}, {"label": "C", "text": "5cm", "correct": false}, {"label": "D", "text": "6cm", "correct": false}], "correct_answer": "B. 4cm", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) 4cm</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Plotting on the partograph should start at 4 cm cervical dilatation during the active phase of labor.</li><li>âž¤ Ref: Page no 152, DC Duttaâ€™s Textbook of Obstetrics 7 th edition</li><li>âž¤ Ref: Page no 152, DC Duttaâ€™s Textbook of Obstetrics 7 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A nulliparous woman presented with 26 weeks of gestation for routine antenatal check-up. Her blood pressure was 150/90 mmHg. What can be the next best step? (FMGE JANUARY 2023)", "options": [{"label": "A", "text": "Serum uric acid levels", "correct": false}, {"label": "B", "text": "Liver Function tests", "correct": false}, {"label": "C", "text": "Complete blood count", "correct": false}, {"label": "D", "text": "Urine dipstick", "correct": true}], "correct_answer": "D. Urine dipstick", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/28/screenshot-2023-09-28-191550.jpg"], "explanation": "<p><strong>Ans. D) Urine dipstick</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In pregnant women with BP > 140/90 mmHg after 20 weeks of gestation, the next best step is to evaluate for proteinuria using a urine dipstick test to screen for pre-eclampsia.</li><li>âž¤ Ref: Duttaâ€™s textbook of Obstetrics page 256, 262</li><li>âž¤ Ref: Duttaâ€™s textbook of Obstetrics page 256, 262</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All the followings are seen in Gestational Diabetes Mellitus except: (INICET NOV 2019)", "options": [{"label": "A", "text": "Malformations", "correct": true}, {"label": "B", "text": "Polyhydramnios", "correct": false}, {"label": "C", "text": "Fetal Macrosomia", "correct": false}, {"label": "D", "text": "Neonatal Hypoglycemia", "correct": false}], "correct_answer": "A. Malformations", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Malformations</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Congenital anomalies are not typically seen with Gestational Diabetes Mellitus (GDM); they are associated with pre-existing overt diabetes mellitus.</li><li>âž¤ Ref: Williamâ€™s textbook of obstetrics 26 th edition pg 2787</li><li>âž¤ Ref: Williamâ€™s textbook of obstetrics 26 th edition pg 2787</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not included in the quadruple screening test? (INICET NOV 2021)", "options": [{"label": "A", "text": "Inhibin B", "correct": true}, {"label": "B", "text": "Unconjugated Estriol (E3)", "correct": false}, {"label": "C", "text": "AFP", "correct": false}, {"label": "D", "text": "hCG", "correct": false}], "correct_answer": "A. Inhibin B", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-279.jpg"], "explanation": "<p><strong>Ans. A) Inhibin B</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The quadruple screening test includes Free Î² hCG, unconjugated Estriol (uE3), Maternal Serum Î±-fetoprotein (AFP), and Inhibin A. Inhibin B is not included in the quadruple test.</li><li>âž¤ Ref: Williamâ€™s textbook of obstetrics 26 th edition</li><li>âž¤ Ref: Williamâ€™s textbook of obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "While discharging a patient who underwent a vesicovaginal fistula repair, which of the following would you recommend? (NEET PG 2022)", "options": [{"label": "A", "text": "Sexual abstinence for 3 months and avoid pregnancy for a year", "correct": true}, {"label": "B", "text": "Sexual abstinence for 3 weeks and avoid pregnancy for 6 months", "correct": false}, {"label": "C", "text": "Sexual abstinence for 6 weeks and avoid pregnancy for a year", "correct": false}, {"label": "D", "text": "Sexual abstinence for 6 months and avoid pregnancy for 6 years", "correct": false}], "correct_answer": "A. Sexual abstinence for 3 months and avoid pregnancy for a year", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Sexual abstinence for 3 months and avoid pregnancy for a year</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Vesicovaginal fistula (VVF) is a type of urinary fistula that commonly arises due to obstetric trauma. Small fistulas can heal spontaneously; however, most established fistulas require surgical repair. The surgical repair is usually performed vaginally after approximately 3 months to allow inflammation to subside. Post-operatively, continuous bladder drainage for 14 days along with antibiotics is recommended to facilitate healing. Following VVF repair, it is recommended that the patient abstain from sexual activity for 3 months to allow the surgical site to heal properly and avoid complications. Additionally, pregnancy should be avoided for a year to ensure the integrity and strength of the repair before subjecting the area to the stresses of pregnancy and childbirth.</li><li>â€¢ Vesicovaginal fistula (VVF) is a type of urinary fistula that commonly arises due to obstetric trauma.</li><li>â€¢ Small fistulas can heal spontaneously; however, most established fistulas require surgical repair.</li><li>â€¢ The surgical repair is usually performed vaginally after approximately 3 months to allow inflammation to subside.</li><li>â€¢ Post-operatively, continuous bladder drainage for 14 days along with antibiotics is recommended to facilitate healing.</li><li>â€¢ Following VVF repair, it is recommended that the patient abstain from sexual activity for 3 months to allow the surgical site to heal properly and avoid complications.</li><li>â€¢ Additionally, pregnancy should be avoided for a year to ensure the integrity and strength of the repair before subjecting the area to the stresses of pregnancy and childbirth.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Sexual abstinence for 3 weeks and avoid pregnancy for 6 months : This duration of abstinence is too short for the proper healing of the surgical site. Additionally, avoiding pregnancy for only 6 months might not provide sufficient time for the repair to gain adequate strength.</li><li>â€¢ Option B. Sexual abstinence for 3 weeks and avoid pregnancy for 6 months</li><li>â€¢ Option C. Sexual abstinence for 6 weeks and avoid pregnancy for a year : While the recommendation to avoid pregnancy for a year is appropriate, 6 weeks of sexual abstinence may still be insufficient for optimal healing of the fistula repair.</li><li>â€¢ Option C. Sexual abstinence for 6 weeks and avoid pregnancy for a year</li><li>â€¢ Option D. Sexual abstinence for 6 months and avoid pregnancy for 6 years : This recommendation is excessively long. While prolonged abstinence can prevent complications, a 6-month period is more than what is typically necessary. Similarly, avoiding pregnancy for 6 years is overly cautious.</li><li>â€¢ Option D. Sexual abstinence for 6 months and avoid pregnancy for 6 years</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Following vesicovaginal fistula repair, patients should be advised to abstain from sexual activity for 3 months and avoid pregnancy for a year to ensure proper healing and reduce the risk of complications.</li><li>âž¤ Ref: Page 439, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li><li>âž¤ Ref: Page 439, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 40-year-old woman comes with a history of postcoital bleeding and a visible mass seen in cervix per speculum. The next step to be done? (INICET NOV 2017)", "options": [{"label": "A", "text": "Conisation", "correct": false}, {"label": "B", "text": "Cryotherapy", "correct": false}, {"label": "C", "text": "Targeted biopsy", "correct": true}, {"label": "D", "text": "Pap smear", "correct": false}], "correct_answer": "C. Targeted biopsy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Targeted biopsy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In a symptomatic patient with a visible cervical lesion and postcoital bleeding, a targeted biopsy is the appropriate next step to obtain a definitive diagnosis.</li><li>âž¤ Ref: Page 327, DC Duttaâ€™a Textbook of gynecology, 6 th edition</li><li>âž¤ Ref: Page 327, DC Duttaâ€™a Textbook of gynecology, 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A couple already has 3 children and has been trying for another one for the last 1 year. However, the husband is diagnosed with hypogonadotropic hypogonadism. Which of the following is/are true? (INICET MAY 2022) Low FSH, low LH High FSH, low LH Oligospermia Low prolactin Low testosterone", "options": [{"label": "A", "text": "1, 2, 3, 4 and 5", "correct": false}, {"label": "B", "text": "1, 2 and 5", "correct": false}, {"label": "C", "text": "2, 3, 4 and 5", "correct": false}, {"label": "D", "text": "1, 3 and 5", "correct": true}], "correct_answer": "D. 1, 3 and 5", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) 1, 3 and 5</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In hypogonadotropic hypogonadism, both FSH and LH levels are low, testosterone levels are low, and oligospermia is often present.</li><li>âž¤ Ref: Page no 232, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li><li>âž¤ Ref: Page no 232, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 62-year-old patient with a history of diabetes and hypertension came with post-menopausal bleeding. Which of the following you will do to evaluate the cause? (INICET MAY 2021)", "options": [{"label": "A", "text": "Pap smear", "correct": false}, {"label": "B", "text": "Visual inspection with iodine", "correct": false}, {"label": "C", "text": "Colposcopy", "correct": false}, {"label": "D", "text": "Endometrial sampling", "correct": true}], "correct_answer": "D. Endometrial sampling", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Endometrial sampling</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Endometrial sampling is done to evaluate a patient presenting with postmenopausal bleeding.</li><li>âž¤ Ref: Page no 560, DC Duttaâ€™s Textbook of Gynecology 6 th edition.</li><li>âž¤ Ref: Page no 560, DC Duttaâ€™s Textbook of Gynecology 6 th edition.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 12 weeks pregnant lady visited the doctor. On ultrasound, it was found she has a low-lying placenta. What is the next best step? (FMGE JANUARY 2024)", "options": [{"label": "A", "text": "Repeat ultrasound at 32 weeks", "correct": true}, {"label": "B", "text": "Repeat ultrasound at 39 weeks", "correct": false}, {"label": "C", "text": "Elective LSCS at 39 weeks", "correct": false}, {"label": "D", "text": "Allow for a normal delivery", "correct": false}], "correct_answer": "A. Repeat ultrasound at 32 weeks", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Repeat ultrasound at 32 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ At 12 weeks gestation, the presence of a low-lying placenta is often not a cause for immediate concern because the placenta typically \"migrates\" upward as the pregnancy progresses. This migration is due to the expansion of the uterus, which effectively moves the placenta away from the cervix. Therefore, the recommended management is to repeat an ultrasound between 28 to 32 weeks to reassess the position of the placenta. By this time, the majority of placentas that were initially low-lying will have moved to a safer position, allowing for a more accurate determination of whether there will be any complications related to placenta previa.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The next best step for a pregnant woman found to have a low-lying placenta at 12 weeks is to repeat the ultrasound at around 32 weeks to reassess the placenta